Differences in the expression of BAFF receptors may be explained by the levels of synergistic CD40 and IL-4 signals known to up-regulate TACI expression and improve CLL cell survival in response to both BAFF and APRIL (21). The gene discussed is TNFRSF13B; the disease is B-cell chronic lymphocytic leukemia.